πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7943626

Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxam

Takeda Pharmaceutical Company Limited Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943593

Compositions comprising inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7943159

Female sex pheromone of the dogwood borer (DWB), Synanthedon scitula, and attraction inhib

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7935693

Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles usef

Rigel Pharmaceuticals, Inc. Β· Granted Tue May 03 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928129

Nanomolar Ξ²-lactamase inhibitors

Northwestern University Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919621

Tricyclic inhibitors of 5-lipoxygenase

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919523

Inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919520

Inhibitors of tace

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7919513

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915305

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7910587

Quinoxalinyl dipeptide hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906650

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906550

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906530

1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

Laboratories Almirall, S.A. Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906523

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7906513

Hydrazide-containing hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902239

Diaminotriazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7902166

Compositions comprising inhibitors of RNA binding proteins and methods of producing and us

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888357

Anti-inflammatory and protein kinase inhibitor compositions and related methods for downre

Northwestern University Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7888332

Hydrazide-containing CFTR inhibitor compounds and uses thereof

The Regents of the University of California Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884119

Triazole derivatives useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7883881

Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879891

Caspase inhibitor prodrugs

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7879856

Diaminothiazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted